Effects of Ghrelin, Corticotrophin-releasing Hormone, and Melanotan-II on Food Intake in Rats with Paraventricular Nucleus Lesions

Abstract

Bilateral lesions of the hypothalamic paraventricular nuclei (PVN) induce hyperphagia and obesity, and ghrelin stimulates appetite in rodents and humans. Conversely, corticotrophin-releasing hormone (CRH) and melanotan-II (MT-II, a synthetic structural homologue of alpha-melanocyte-stimulating hormone, αMSH) inhibit feeding behavior. The purpose of the present study was to determine whether these peptides are involved in the hyperphagia and obesity induced by PVN lesions. After bilateral electrolytic lesions of the PVN, rats were given ghrelin intraperitoneally (i. p.), or intracerebroventricular (i. c. v.) infusion of CRH or MT-II. We measured the cumulative food intake (FI) for 4 h after ghrelin injection in rats fed ad lib, and the changes in FI at 15 min, 30 min, 1 h, and 2 h after infusion of CRH and MT-II in rats fasted for 24 h. Ghrelin significantly increased cumulative FI, with maximal response 3 h and 4 h after injection, and at these times, the FI of PVN-lesioned rats was greater than that of sham-operated rats. CRH significantly decreased FI in all experimental animals, but at 1 h, there was a more powerful inhibitory effect on FI in the PVN-lesioned group than in the sham-operated group. MT-II decreased FI in sham-operated, but not in PVN-lesioned rats. Thus, ghrelin and CRH showed more potent orexigenic and anorectic effects in PVN-lesioned rats, respectively, but MT-II lost its inhibitory action on feeding behavior. These results suggest that the hyperphagia and obesity induced by PVN lesions may be related to an increased orexigenic action of ghrelin due to the destruction of endogenous CRH and αMSH receptors.

Key words

paraventricular nucleus - ghrelin - corticotrophin-releasing hormone - alpha-melanocyte-stimulating hormone - melanotan-II - hypothalamus - feeding behavior

References

• 1 Bruhn TO, Plotsky PM, Vale WW. Effect of paraventricular lesions on corticotropin-releasing factor (CRF)-like immunoreactivity in the stalk-median eminence: studies on the adrenocorticotropin response to ether stress and exogenous CRF.  Endocrinology. 1984;  114 57-62
• 2 Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks.  Science. 1995;  269 546-549
• 3 Cheung CC, Clifton DK, Steiner RA. Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus.  Endocrinology. 1997;  138 4489-4492
• 4 Choi S, Sparks R, Clay M, Dallman MF. Rats with hypothalamic obesity are insensitive to central leptin injections.  Endocrinology. 1999;  140 4426-4433
• 5 Choi YH, Li C, Page K, Westby A, Della-Fera MA, Lin J, Hartzell DL, Baile CA. Melanocortin receptors mediate leptin effects on feeding and body weight but not adipose apoptosis.  Physiol Behav. 2003;  79 795-801
• 6 Cowley MA, Smith RG, Diano S, Tschop M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esterman M, Heiman ML, Garcia-Segura LM, Nillni EA, Mendez P, Low MJ, Sotonyi P, Friedman JM, Liu H, Pinto S, Colmers WF, Cone RD, Horvath TL. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis.  Neuron. 2003;  37 649-661
• 7 Druce MR, Wren AM, Park AJ, Milton JE, Patterson M, Frost G, Ghatei MA, Small C, Bloom SR. Ghrelin increases food intake in obese as well as lean subjects.  Int J Obes Relat Metab Disord. 2005;  29 1130-1136
• 8 Elias CF, Kelly JF, Lee CE, Ahima RS, Drucker DJ, Saper CB, Elmquist JK. Chemical characterization of leptin-activated neurons in the rat brain.  J Comp Neurol. 2000;  423 261-281
• 9 Faulconbridge LF, Cummings DE, Kaplan JM, Grill HJ. Hyperphagic effects of brainstem ghrelin administration.  Diabetes. 2003;  52 2260-2265
• 10 Gilg S, Lutz TA. The orexigenic effect of peripheral ghrelin differs between rats of different age and with different baseline food intake, and it may in part be mediated by the area postrema.  Physiol Behav. 2006;  87 353-359
• 11 Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM. Weight-reducing effects of the plasma protein encoded by the obese gene.  Science. 1995;  269 543-546
• 12 Hewson AK, Dickson SL. Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats.  J Neuroendocrinol. 2000;  12 1047-1049
• 13 Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Wakabayashi I. Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression.  Endocrinology. 2000;  141 4797-4800
• 14 Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Wakabayashi I. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats.  Diabetes. 2001;  50 2438-2443
• 15 Klok MD, Jakobsdottir S, Drent ML. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review.  Obes Rev. 2007;  8 21-34
• 16 Koegler FH, Grove KL, Schiffmacher A, Smith MS, Cameron JL. Central melanocortin receptors mediate changes in food intake in the rhesus macaque.  Endocrinology. 2001;  142 2586-2592
• 17 Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach.  Nature. 1999;  402 656-660
• 18 Lawrence CB, Snape AC, Baudoin FM, Luckman SM. Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers.  Endocrinology. 2002;  143 155-162
• 19 Lennard DE, Eckert WA, Merchenthaler I. Corticotropin-releasing hormone neurons in the paraventricular nucleus project to the external zone of the median eminence: a study combining retrograde labeling with immunocytochemistry.  J Neuroendocrinol. 1993;  5 175-181
• 20 Liposits Z, Lengvari I, Vigh S, Schally AV, Flerko B. Immunohistological detection of degenerating CRF-immunoreactive nerve fibers in the median eminence after lesion of paraventricular nucleus of the rat. A light and electron microscopic study.  Peptides. 1983;  4 941-953
• 21 Liposits Z, Paull WK. Association of dopaminergic fibers with corticotropin releasing hormone (CRH)-synthesizing neurons in the paraventricular nucleus of the rat hypothalamus.  Histochemistry. 1989;  93 119-127
• 22 Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain.  Mol Endocrinol. 1994;  8 1298-1308
• 23 Mountjoy KG, Wong J. Obesity, diabetes and functions for pro-opiomelanocortin-derived peptides.  Mol Cell Endocrinol. 1997;  128 171-177
• 24 Murphy B, Nunes CN, Ronan JJ, Hanaway M, Fairhurst AM, Mellin TN. Centrally administered MT-II affects feeding, drinking, temperature, and activity in the Sprague-Dawley rat.  J Appl Physiol. 2000;  89 273-282
• 25 Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S. A role for ghrelin in the central regulation of feeding.  Nature. 2001;  409 194-198
• 26 Pellegrino LJ, Pellegrino AS, Cushman AJ. A stereotaxic atlas of the rat brain. New York: Plenum Press 1979
• 27 Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice.  Science. 1995;  269 540-543
• 28 Ruter J, Kobelt P, Tebbe JJ, Avsar Y, Veh R, Wang L, Klapp BF, Wiedenmann B, Tache Y, Monnikes H. Intraperitoneal injection of ghrelin induces Fos expression in the paraventricular nucleus of the hypothalamus in rats.  Brain Res. 2003;  991 26-33
• 29 Schwartz MW, Seeley RJ, Woods SC, Weigle DS, Campfield LA, Burn P, Baskin DG. Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus.  Diabetes. 1997;  46 2119-2123
• 30 Seeley RJ, Yagaloff KA, Fisher SL, Burn P, Thiele TE, Dijk G van, Baskin DG, Schwartz MW. Melanocortin receptors in leptin effects.  Nature. 1997;  390 349
• 31 Shor-Posner G, Azar AP, Insinga S, Leibowitz SF. Deficits in the control of food intake after hypothalamic paraventricular nucleus lesions.  Physiol Behav. 1985;  35 883-890
• 32 Shrestha YB, Wickwire K, Giraudo SQ. Action of MT-II on ghrelin-induced feeding in the paraventricular nucleus of the hypothalamus.  Neuroreport. 2004;  15 1365-1367
• 33 Sun G, Narita K, Murata T, Honda K, Higuchi T. Orexin-A immunoreactivity and prepro-orexin mRNA expression in hyperphagic rats induced by hypothalamic lesions and lactation.  J Neuroendocrinol. 2003;  15 51-60
• 34 Thiele TE, Dijk G van, Yagaloff KA, Fisher SL, Schwartz M, Burn P, Seeley RJ. Central infusion of melanocortin agonist MTII in rats: assessment of c-Fos expression and taste aversion.  Am J Physiol. 1998;  274 R248-R254
• 35 Toshinai K, Date Y, Murakami N, Shimada M, Mondal MS, Shimbara T, Guan JL, Wang QP, Funahashi H, Sakurai T, Shioda S, Matsukura S, Kangawa K, Nakazato M. Ghrelin-induced food intake is mediated via the orexin pathway.  Endocrinology. 2003;  144 1506-1512
• 36 Yamanaka A, Beuckmann CT, Willie JT, Hara J, Tsujino N, Mieda M, Tominaga M, Yagami K, Sugiyama F, Goto K, Yanagisawa M, Sakurai T. Hypothalamic orexin neurons regulate arousal according to energy balance in mice.  Neuron. 2003;  38 701-713

Correspondence